Authors' recommendations: The use of PR improves short-term exercise capacity, HRQL, and mental health outcomes for patients with COPD. More work is needed to confirm the factors that contribute to the successfullong-term management of COPD after PR. There is limited information on the effectiveness of specific elements of PR programs. There are issues relating to patient characteristics and theoperation of PR and maintenance programs that require consideration by those who establish or implement these services.The cost-effectiveness of PR will depend on the duration of benefits. If the duration of the efficacy of PR is18 months, the incremental cost-effectiveness ratio or ICER of usual care plus PR compared with usual care is $27,924 per additional QALY gained. In the most likely scenario from the budget impact analysis, an additional 15,900 persons per year would need PR, and anadditional budget of $19 million would be required annually.

Project Status: Completed

URL for project: http://www.cadth.ca/media/pdf/H0482_COPD_tr_e.pdf

Year Published: 2010

URL for published report: http://www.cadth.ca/index.php/en/hta/reports-publications/search/publication/962

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Canada

Organisation Name: Canadian Agency for Drugs and Technologies in Health

Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;

Contact Name: requests@cadth.ca

Contact Email: requests@cadth.ca

Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)